RNA Centre of Excellence
Accelerating innovation in RNA vaccines and therapeutics.
A new Centre for industry
CPI’s RNA Centre of Excellence is a multi-million pound GMP facility based in Darlington in the North East of England, directly next to our National Biologics Manufacturing Centre. It’s currently the only UK-based site with the capability to develop and manufacture lipid nanoparticle encapsulated messenger and self-amplifying RNA vaccines and therapies ready for use in early-phase clinical trials.
Benefitting patients and fighting future health emergencies
We played a key role in the accelerated development of COVID-19 vaccines as part of the UK Government’s Vaccine Taskforce. As a result, we’ve built the knowledge and networks to support every stage of RNA development and scale-up and help the pharma industry develop next-generation medicine manufacturing innovations to deliver tomorrow’s vaccines and therapeutics. Our RNA Centre of Excellence has the capacity to manufacture millions of vaccine doses per year in the event of a future health emergency.
![A photo of a CPI scientist standing next to our Ambr250. A photo of a CPI scientist standing next to our Ambr250.](https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=1920&h=1080&q=60&fm=jpg&fit=crop&dm=1621437116&s=e35f66710cbef942561816ebfb9f32e7 1920w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=1120&h=630&q=60&fm=jpg&fit=crop&dm=1621437116&s=19f3b6a0eb55d3e3859f35d5d1eb75f5 1120w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=2240&h=1260&q=45&fm=jpg&fit=crop&dm=1621437116&s=aa3f2b8817ff5fba3a13f213f1f1efbf 2240w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=800&h=450&q=60&fm=jpg&fit=crop&dm=1621437116&s=680d3f9b3f77d223ea8a9009b8b65545 800w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=1600&h=900&q=45&fm=jpg&fit=crop&dm=1621437116&s=386c8b8929a1fcff5b1d66e9c4547126 1600w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=480&h=270&q=60&fm=jpg&fit=crop&dm=1621437116&s=fc182427fa32654c5c24ad6f609e2689 480w, https://optimise2.assets-servd.host/smart-hoopoe/production/content/images/Ambr250.png?w=960&h=540&q=45&fm=jpg&fit=crop&dm=1621437116&s=772ff2748e25ea9af6fb819d27f666ca 960w)
An all-encompassing offer
We have the largest pool of RNA biomanufacturing experts in the UK and offer complementary drug delivery systems like lipid nanoparticles. Our RNA Centre of Excellence is set up for the production of clinical phase material with an associated MHRA licence, including validated equipment, trained staff, a quality management system and support functions. This combination of in-house expertise, world-class facilities and state-of-the-art equipment means we can support from technical transfer through to early-stage technology readiness.
Future-proofing the industry
Our RNA Training Academy provides industry-leading training within RNA and LNP technology developed by our in-house scientists. Guided by our independent Advisory Committee of experts across academia and industry, the academy provides CPD-certified learning covering a wide range of topic areas.